ONCAlert | Upfront Therapy for mRCC
News
Osimertinib/Cetuximab Inhibits Tumor Growth in EGFR-Mutant NSCLC
4:17 PM, Fri October 18, 2019
FDA Approves Romiplostim for Earlier Use in Adults With ITP
2:56 PM, Fri October 18, 2019
Challenges Remain in Hepatocellular Carcinoma Surveillance of Patients With NASH
7:33 PM, Thu October 17, 2019
FDA Grants Priority Review of DS-8201 for HER2+ Metastatic Breast Cancer
4:52 PM, Thu October 17, 2019
Langer Highlights the Potential Benefits of Postchemoradiation Immunotherapy in NSCLC
4:23 PM, Thu October 17, 2019
Novel Agent IMG-7289 Appears Well Tolerated in Patients With Myelofibrosis
2:47 PM, Thu October 17, 2019
TAS-102 Shows Improvement in Overall Survival for Gastric/GEJ Cancer
8:00 PM, Wed October 16, 2019
Ruxolitinib Improves ORR in Steroid-Refractory aGVHD in Early Phase III Trial Results
5:00 PM, Wed October 16, 2019
